ABSTRACT
MATERIALS AND METHODS
A cross sectional study was conducted in Department of Biochemistry at Universal College of Medical Sciences (UCMS), Bhairahawa, Nepal. Thyroid disorders was classified as euthyroidism, TSH within the normal range, subclinical hypothyroidism, TSH >4.7mIU/L but normal thyroid hormones, primary hypothyroidism, TSH >4.7mIU/L and primary hyperthyroidism, TSH<0.5mIU/L. Only suspected thyroid disorder patients were enrolled in the study. The consent was taken from each subject and the ethical approval for the study was provided by institute review board of UCMS, Bhairahawa. Serum fT / fT4 and TSH estimations 3 4 were carried out by competitive ELISA method and Sand- 5 wich double antibody ELISA method respectively using commercially supplied reagents (Human, Germany). The criterion for dyslipidemia was obtained by National Cholesterol Education Expert Panel/ Adult Treatment Protocol III (NCEP/ATPIII).
STATISTICAL ANALYSIS
The data were entered in IBM SPSS Windows version 22 and were expressed as mean and SD values. Independent ttest and Oneway Analysis of Variance (ANOVA) were used. Pearson's correlation coefficient was used to find association between different variables. A P value < 0.05 was considered statistically significant. 6, 7, 8 dyslipidemia But in patients with overt hypothyroidism, activity of HMG-CoA reductase tends to decrease while TC 9, 10 and LDL-C levels are increased. This can be explained as increased thyroid hormones leads to decresedcatabolism of 11, 12 LDL and IDL Hyperthyroidism canalso be the contributory factor that may cause unexpected improvement of lipid profile 13 in hyperlipidemic patients Since, hyperthyroidism whether overt or subclinical , there is decrease in LDLand HDL cholesterol resulting enhanced oxidation of LDL that depends 14 on level of FT4. Decrease in HDL-C levels is associated with increased CETP-mediated transfer of cholesteryl esters from HDL to VLDL and increased HL-mediated catabolism of 15, 16 HDL . 2 Thyroid hormones have been positively correlated with 17 18 endothelial and cardiac function like atherosclerosis. Defects in lipid metabolism leads to the development of 19, 20 atherosclerotic coronary artery (CAD). CVD is not only related with the levels of LDL-C, but even depends on 21 qualitative composition of LDL-C. Hence, alterations in thyroid function not only alter the serum concentration level but also result in changes in the composition and transport of lipoproteins.
RESULTS

Out
Regarding HDL metabolism, thyroid hormones increase 22 cholesteryl ester transport protein (CETP) activity. T 3 upregulates LDL receptors by controlling the LDL receptors 23 gene activation. Among different thyroid disorder, hypothyroidism is prevalent as one of the common causes for 24 secondary dyslipidemia. Therefore, before commencing any therapy for lipid disorder, the evaluation of thyroid function is needed.
Biochemical screening for thyroid dysfunction is critical in all dyslipidemic patients as well as in all patients with unexpected improvement or worsening of their lipid profile. Hence our study can revealed the close correlation of thyroidal illness and various lipid parameters like triglycerides, cholesterol etc.. This is the first kind of study that is undertaking in southwest region of Nepal. (47.11±13.10) was found to be associated with hypothyroid cases rather than euthyroid ones suggesting a defect in HDL metabolism. Although the observation was confronting one 12, 31 but some of the studies also reproduce the similar results. There were significant difference in the thyroid hormones (p<0.0001), HDL cholesterol (p<0.009), TG/HDL ratio (p<0.024) and Non-HDL/HDL ratio (p<0.033) respectively. Our study showed that mean HDL level was significantly higher in hypothyroidism but there was no statistically significant difference in the mean LDL, VLDL, cholesterol and triglyceride levels. LDl cholesterol was higher in hypothyroid patients as compared to others .This suggest that hypothyroid patients are at high risk in developing cardiovascular diseases.
Regarding TG/HDL and Non HDL/HDL ratio, the highest average ratio was seen in subclinical hypothyroid patient (p = 0.024, p = 0.033 )since TG and Non HDL cholesterol were found to be markedly increased in such cases. Some studies have also shown that SH dyslipidemia may also be 12, 32 accompanied by increased TGs and decreased HDL-C 33 levels.
Different parameters of lipid spectrum was found to be negatively correlated with thyroid hormones (fT3 and fT4).meanwhile positive correlation was seen with that of 34 TSH level. Like some other studies , HDL cholesterol was found to be negatively correlated with TSH but the variables observed to be not statistically significant.
CONCLUSION
Our study revealed the close association of thyroidal illness with dyslipidemia with increased TG, low HDL, increased TG/HDL and Non-HDL/HDL. The increased TG/HDL and/or Non-HDL/HDL could be better indicator than single lipid abnormality. Hence, biochemical screening for thyroid dysfunction is critical in all dyslipidemic patients and proper treatment in designated time will prevent the patients from future consequences of developing cardiovascular disease (CVD) like artherosclerosis.
